Patents
Across the telecommunications, consumer products, food and beverage, pharmaceutical, biotechnology, IT and electronics sectors and more, we can provide assistance and advice in litigation, transactions, risk management and strategic matters involving patents. We focus on maximising the commercial value and return from patents for our clients.

Professionals

Noel Kim
Consultant

Tin-Lok Shea
Partner
Related Insights
View MorePatents,IP Strategy & Management
17 September 2021
Is it possible for an AI (Artificial Intelligence) to be an inventor?
Is it possible for an AI (Artificial Intelligence) to be an inventor? - Thaler v Commissioner of Patents [2021] FCA 879 Summary: ● Dr Stephen Thaler (Thaler) filed an Australian patent application for an invention that was created autonomously by an AI system called ‘DABUS’. ● IP Australia rejected the patent application, determining that only a human can be named as an inventor for an Australian patent.
Patents
23 October 2020
IP Australia Fee Changes from 1 October 2020
IP Australia’s 2019-2020 fee review has resulted in changes to various official fees within the Australian Government Charging Framework. The aim of the changes is to ensure the recovery of fees from the administration of intellectual property rights systems. The changes are effective 1 October 2020.
Patents
03 September 2018
Preliminary Discovery
Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCAFC 193. Summary: “Between war and war”. This famous phrase from the book “The Art of War” means that if you know the situation you are in well, you can fight a hundred times and not be at risk.